Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

NCT07277387

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +16 more
Locations: Hospital Universitari Vall d'Hebron Barcelona, Spain

Complejo Asistencial Universitario de Salamanca Salamanca, Spain

Hospital Universitario Virgen Macarena Seville, Sevilla, Spain

View Trial Details

Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

NCT00991094

Conditions: Breast Carcinoma, Breast Diseases, Breast Neoplasms, +30 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Response to Influenza Vaccination in Pediatric Oncology Patients

NCT05384288

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +5 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

NCT06184321

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

NCT05436418

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, +8 more
Locations: City of Hope Duarte, California, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

NCT04959175

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

NCT06401356

Conditions: Advanced Malignancies, Hematologic Diseases, Hematologic Malignancy, +5 more
Locations: University of California LA Los Angeles, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Northwestern University Chicago, Illinois, United States

Uni Of Michigan Health System Ann Arbor, Michigan, United States

View all 15 locations

View Trial Details

Recruiting

Increasing Knowledge and Interest in Cancer Clinical Trials

NCT06501040

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

NCT04844866

Conditions: Diffuse Large B-cell Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations: LKH - Medizinische Universitaet Graz Graz, Austria

Universitatsklinikum Innsbruck Universitatsklinik fur Innere Medizin V Innsbruck, Austria

Ordensklinikum Linz GmbH Elisabethinen Linz, Austria

Medizinische Universitaet Wien - Allgemeines Krankenhaus der Stadt Wien (AKH) Vienna, Austria

View all 51 locations

View Trial Details

Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

NCT04935684

Conditions: Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
Locations: Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France

Service Maladies du sang CHU Angers Angers, France

Hématologie clinique CHU Besançon Besançon, France

Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France

View all 20 locations

View Trial Details